YESHWANT KRISHNA sold 1.1% of their position (48.58K shares) of VERVE THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.51M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 11/8/2022ACC: 0000899243-22-035380
Director10% Owner
Since Jun 2021
-97.17K
Net shares
Net seller
$1.51M
Total sold
3
Open market trades
0B · 3S
4
Total transactions
97.17K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−48.58K
Price / share
—
Trade value
—
% of position
0.8%
11/4/2022
6.16M→6.11M
Common Stock
Indirect
Shares
−47.69K
Price / share
$31.12
Trade value
$1.48M
% of position
1.1%
11/4/2022
4.31M→4.26M
Common Stock
Indirect
Shares
−650.00
Price / share
$31.99
Trade value
$20.79K
% of position
0.0%
11/4/2022
4.26M→4.26M
Common Stock
Indirect
Shares
−243.00
Price / share
$32.90
Trade value
$7.99K
% of position
0.0%
11/4/2022
4.26M→4.26M
Total
Net shares
−97.17K
Net value
-$1.51M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/4/2022 | J · J | −48.58K | — | — | 0.8% | 6.16M | 6.11M |
| Common Stock Indirect | 11/4/2022 | S · Sale | −47.69K | $31.12 | $1.48M | 1.1% | 4.31M | 4.26M |
| Common Stock Indirect | 11/4/2022 | S · Sale | −650.00 | $31.99 | $20.79K | 0.0% | 4.26M | 4.26M |
| Common Stock Indirect | 11/4/2022 | S · Sale | −243.00 | $32.90 | $7.99K | 0.0% | 4.26M | 4.26M |
| Total | −97.17K | -$1.51M | ||||||
Derivative Transactions0
No derivative transactions reported